Ratio Therapeutics

aid: ratio-therapeutics
name: Ratio Therapeutics
description: 'Ratio Therapeutics Inc. is a clinical-stage pharmaceutical company headquartered at One Design Center Place
  in Boston, Massachusetts, developing next-generation precision radiopharmaceuticals for solid tumors. Founded in 2022 by
  Jack Hoppin, Ph.D. and John Babich, Ph.D., the company pairs two proprietary R&D platforms — Trillium, a tunable albumin-binding
  targeting scaffold that modulates pharmacokinetics, and Macropa, a bifunctional chelator built for the alpha emitter actinium-225
  — to improve drug availability, tumor delivery and tumor loading. Its lead program, [Ac-225]RTX-2358, is a FAP-targeted
  radiotherapeutic in the ATLAS Phase 1/2 trial, alongside a next-generation GRPR program, mono- and bispecific radioligand
  therapies, and PET imaging assets. Ratio has licensing and collaboration agreements with Novartis, Merck, Bayer and Lantheus,
  isotope supply agreements with Nusano, TerraPower Isotopes and PanTera, and manufacturing partnerships with PharmaLogic
  and Eckert & Ziegler. It closed a $70 million Series C in July 2026, bringing total capital raised past $240 million. Ratio
  is a therapeutics developer rather than a software vendor: it publishes no developer program, no public API and no machine-readable
  API contract.'
url: https://raw.githubusercontent.com/api-evangelist/ratio-therapeutics/refs/heads/main/apis.yml
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - security
  generated: '2026-09-02'
  method: derived
image: https://i0.wp.com/ratiotx.com/wp-content/uploads/2023/03/ratiologo_clr_sansblock.jpg?fit=1325%2C588&ssl=1
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Healthcare
- Oncology
- Radiopharmaceuticals
- Drug Discovery
- Clinical Trials
- Precision Medicine
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/ratio-therapeutics-domain-security.yml
- type: Website
  url: https://ratiotx.com/
- type: Blog
  url: https://ratiotx.com/blog/
- type: News
  url: https://ratiotx.com/news/
- type: Support
  url: https://ratiotx.com/contact-us/
- type: Careers
  url: https://ratiotx.com/careers/
- type: GitHubOrganization
  url: https://github.com/ratiotx
- type: LinkedIn
  url: https://www.linkedin.com/company/ratio-therapeutics/
- type: LLMsTxt
  url: llms/ratio-therapeutics-llms.txt
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Ratio Therapeutics is a clinical-stage radiopharmaceutical developer whose product is a drug pipeline ([Ac-225]RTX-2358
    and the Trillium/Macropa platforms); ratiotx.com is a twenty-page WordPress.com marketing site where every contract-discovery
    path — /openapi.json, /swagger.json, /v1/openapi.json, /api-docs, /docs, /redoc, /graphql — returns the theme's 404, the
    company's GitHub organization at github.com/ratiotx has zero public repositories, and the only machine-readable surface
    is the CMS's default, undocumented /wp-json/ endpoint rather than a product API.
  evidence:
  - url: https://ratiotx.com/
    status: 200
  - url: https://ratiotx.com/openapi.json
    status: 404
  - url: https://ratiotx.com/swagger.json
    status: 404
  - url: https://ratiotx.com/api-docs
    status: 404
  - url: https://ratiotx.com/graphql
    status: 404
  - url: https://ratiotx.com/.well-known/api-catalog
    status: 404
  - url: https://ratiotx.com/.well-known/agent-card.json
    status: 404
  - url: https://ratiotx.com/.well-known/agent.json
    status: 404
  - url: https://ratiotx.com/llms.txt
    status: 200
  - url: https://ratiotx.com/wp-json
    status: 200
  - url: https://github.com/ratiotx
    status: 200
  checked: '2026-08-26'